Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Faculty Presentations)Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Faculty Presentations)
Martin Hutchings, MD, PhD
Senior Consultant Department of Haematology and Phase 1 Unit Rigshospitalet, Copenhagen University Hospital Professor of Clinical Lymphoma Research Department of Clinical Medicine, University of Copenhagen Copenhagen, Denmark
Loretta J Nastoupil, MD
Associate Professor Section Chief, Indolent Lymphoma Department of Lymphoma/Myeloma The University of Texas MD Anderson Cancer Center Houston, Texas |